Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure

Chemico-Biological Interactions

Volumn 187, Issue 1-3, 2010, Pages 416-420

  Haigh, Julian R ^a   Adler, Michael ^b   Apland, James P ^b   Deshpande, Sharad S ^b   Barham, Charles B ^a   Desmond, Patrick ^a   Koplovitz, Irwin ^b   Lenz, David E ^b   Gordon, Richard K ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Acetylcholinesterase; Hemi diaphragm muscle; Marmoset; Pyridostigmine bromide; Soman; WRAIR cholinesterase assay

Indexed keywords

ACETYLCHOLINESTERASE; ATROPINE; PRALIDOXIME; PYRIDOSTIGMINE; SOMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; CONTROLLED STUDY; DIAPHRAGM; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; INTOXICATION; LETHAL DOSE; LOW DRUG DOSE; MALE; MARMOSET; NONHUMAN;

ANIMALIA; CALLITHRIX JACCHUS; MARMOSETS; PRIMATES;

EID: 77955513057     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.02.003     Document Type: Article

References (17)

1. Taylor P. Anticholinesterase agents. Goodman and Gilman's The Pharmacological Basis of Therapeutics 2006, 201-216. McGraw-Hill, New York. 11th edition. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
2. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004, 38:151-216.
3. Nigg H.N., Knaak J.B. Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure. Rev. Environ. Contam. Toxicol. 2000, 163:29-111.
4. Dunn M.A., Sidell F.R. Progress in medical defense against nerve agents. JAMA 1989, 262:649-652.
5. Newmark J. Nerve agents: pathophysiology and treatment of poisoning. Semin. Neurol. 2004, 24:185-196.
6. Bencsura A., Enyedyo I., Kovach I.M. Origins and diversity of the aging reaction in phosphonate adducts of serine hydrolase enzymes: what characteristics of the active site do they probe?. Biochemistry 1995, 34:8989-8999.
7. Mazor O., Cohen O., Kronman C., Raveh L., Stein D., Ordentlich A., Shafferman A. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase. Mol. Pharmacol. 2008, 74:755-763.
8. Haigh J.R., Johnson S.R., Peppernay A., Mattern P.J., Garcia G.E., Doctor B.P., Gordon R.K., Aisen P.S. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase. Chem. Biol. Interact. 2008, 175:380-386.
9. Albuquerque E.X., Pereira E.F.R., Fawcett W.P., Aracava Y., Randall W.R., Hamilton T.A., Kan R.K., Romano J.A., Adler M. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. Proc. Natl. Acad. Sci. 2006, 103:13220-13225.
10. Eckert S., Eyer P., Worek F. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge. Toxicology 2007, 233:180-186.
11. Dirnhubrt P., French M.C., Green D.M., Leadbeater L., Stratton J.A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 1979, 31:295-299.
12. Stevens D., Scott E.A., Bowditch A.P., Griffiths G.D., Pearce P.C. Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets. Pharmacol. Biochem. Behav. 2006, 84:207-218.
13. Philippens I.H., Vanwersch R.A., Groen B., Olivier B., Bruijnzeel P.L., Melchers B.P. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible post-intoxication incapacitation. Toxicol. Sci. 2000, 53:84-91.
14. Gordon R.K., Haigh J.R., Garcia G.E., Feaster S.R., Riel M.A., Lenz D.E., Aisen P.S., Doctor B.P. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman. Chem. Biol. Interact. 2005, 157-158:239-246.
15. Adler M., Maxwell D.M., Filbert M.G., Deshpande S.S. Contribution of direct actions of the oxime HI-6 in reversing soman-induced muscle weakness in the rat diaphragm. Eur. J. Pharmacol. 1994, 270:25-33.
16. Maxwell D.M., Vlahacos C.P., Lenz D.E. A pharmacodynamic model for soman in the rat. Toxicol. Lett. 1988, 43:175-188.
17. Heffron P.F., Hobbiger F. Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies. Br. J. Pharmacol. 1979, 66:323-329.